Literature DB >> 10665650

Frequent allelic imbalance on chromosome 18q21 in early superficial colorectal cancers.

Y Akiyama1, T Arai, H Nagasaki, O K Yagi, A Nakahata, T Nakajima, Y Ohkura, T Iwai, K Saitoh, Y Yuasa.   

Abstract

Genetic alterations in early superficial colorectal cancers have rarely been reported. In the present study, we searched for alterations in the APC and p53 genes in 27 superficial (20 depressed and 7 elevated) and 21 protruding colorectal cancers with submucosal invasion by means of PCR-single strand conformation polymorphism. Allelic imbalance (AI) on five loci, i.e., 1p34-36, 8p21-22, 14q32, 18q21 and 22q12-13, was also analyzed. Since a high incidence of 18q21 AI was detected in the superficial depressed cases, we further screened for alterations in Smad2, Smad4 and DCC. APC alterations were observed in three superficial depressed, one superficial elevated, and 11 protruding colorectal cancers, indicating that the frequency of APC alterations in superficial depressed cases was significantly lower than that in the protruding ones. There was no significant association between p53 alterations and macroscopic types. AI on 18q21 (13/20, 65%) was much higher than those on the other four loci in the superficial depressed cases. Moreover, the frequency of 18q21 AI in the superficial depressed cases was significantly higher than that in the protruding ones. Smad4 alterations were only detected in 1 of the 13 superficial depressed and 3 of the 17 protruding cases, while Smad2 and DCC alterations were not detected in any case examined. These data suggest that the carcinogenetic pathways of protruding and superficial depressed colorectal cancers are different, and that alterations of tumor suppressor gene(s) located on 18q21 other than Smad2, Smad4 and DCC might be associated with most superficial depressed colorectal cancers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10665650      PMCID: PMC5926027          DOI: 10.1111/j.1349-7006.1999.tb00716.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  34 in total

1.  Genetic alterations are frequent in APC but rare in the TGF-beta type II receptor gene in cancer in adenomas of the colon.

Authors:  Y Akiyama; O K Yagi; T Ishikawa; H Nagasaki; K Saitoh; Y Yuasa
Journal:  Cancer Lett       Date:  1998-03-13       Impact factor: 8.679

2.  General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part I. Clinical classification. Japanese Research Society for Cancer of the Colon and Rectum.

Authors: 
Journal:  Jpn J Surg       Date:  1983-11

3.  Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.

Authors:  W M Korn; T Yasutake; W L Kuo; R S Warren; C Collins; M Tomita; J Gray; F M Waldman
Journal:  Genes Chromosomes Cancer       Date:  1999-06       Impact factor: 5.006

4.  Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.

Authors:  A B Sparks; P J Morin; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  1998-03-15       Impact factor: 12.701

5.  Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors.

Authors:  T Ried; R Knutzen; R Steinbeck; H Blegen; E Schröck; K Heselmeyer; S du Manoir; G Auer
Journal:  Genes Chromosomes Cancer       Date:  1996-04       Impact factor: 5.006

6.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

7.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

8.  The problem of de novo colorectal carcinoma.

Authors:  S Kudo; S Tamura; S Hirota; Y Sano; H Yamano; M Serizawa; T Fukuoka; H Mitsuoka; T Nakajima; H Kusaka
Journal:  Eur J Cancer       Date:  1995 Jul-Aug       Impact factor: 9.162

9.  Allelic loss of chromosome 18q and prognosis in colorectal cancer.

Authors:  J Jen; H Kim; S Piantadosi; Z F Liu; R C Levitt; P Sistonen; K W Kinzler; B Vogelstein; S R Hamilton
Journal:  N Engl J Med       Date:  1994-07-28       Impact factor: 91.245

10.  Somatic alterations of the SMAD-2 gene in human colorectal cancers.

Authors:  Y Takagi; H Koumura; M Futamura; S Aoki; K Ymaguchi; H Kida; H Tanemura; K Shimokawa; S Saji
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

View more
  5 in total

1.  Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.

Authors:  A Maitra; K Molberg; J Albores-Saavedra; G Lindberg
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas.

Authors:  Tatsuya Ando; Tamotsu Sugai; Wataru Habano; Yu-Fei Jiao; Kazuyuki Suzuki
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

3.  Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5'-UTR splice variants with altered translational activities.

Authors:  Neville J Butcher; Ajanthy Arulpragasam; Hui Li Goh; Tamara Davey; Rodney F Minchin
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

4.  Involvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma.

Authors:  Shinichi Mukai; Toru Hiyama; Shinji Tanaka; Masaharu Yoshihara; Koji Arihiro; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

5.  Down-regulation of drs mRNA in colorectal neoplasms.

Authors:  Ken-ichi Mukaisho; Masashi Suo; Misuzu Shimakage; Ryoji Kushima; Hirokazu Inoue; Takanori Hattori
Journal:  Jpn J Cancer Res       Date:  2002-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.